RNS Number : 8663R Renalytix PLC 10 November 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Convenes Expert Panel at VA Healthcare Summit Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease NEW
RNS Number : 7276R Renalytix PLC 09 November 2021 Renalytix plc ("Renalytix" or the "Company") St. Joseph's Health and Renalytix Partner to Advance Value-Based Kidney Health in New York Partnership expands doctor and patient access to advanced prognosis and coordinated care management of
RNS Number : 9254Q Renalytix PLC 01 November 2021 Renalytix plc (" Renalytix " or the " Company ") Issue of shares and Total Voting Rights NEW YORK , November 1, 2021 - Renalytix plc (AIM: RENX) announces that it has issued and allotted 68,224 ordinary shares of 0.25 pence each in the
RNS Number : 7882P Renalytix PLC 21 October 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Reports Full Year Fiscal 2021 Results LONDON and SALT LAKE CITY , October 21, 2021 - Renalytix plc (NASDAQ: RNLX), (LSE : RENX) an artificial intelligence-enabled in vitro
RNS Number : 4032O Renalytix PLC 08 October 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21 LONDON and SALT LAKE CITY , October 8, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced
RNS Number : 2788O Renalytix PLC 07 October 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals Jed Fulk Appointed Vice President Sales, Government Accounts NEW YORK and SALT LAKE CITY , October 7, 2021 -
RNS Number : 0377M Renalytix PLC 16 September 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 8680L Renalytix PLC 15 September 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 8670L Renalytix PLC 15 September 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 7773L Renalytix PLC 14 September 2021 This announcement contains inside information Renalytix plc (" Renalytix " or the " Company ") Update on MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics NEW YORK , September 14, 2021 - Renalytix
